Literature DB >> 22228906

Decreased Toll-interacting protein and peroxisome proliferator-activated receptor γ are associated with increased expression of Toll-like receptors in colon carcinogenesis.

Pedro Pimentel-Nunes1, Nádia Gonçalves, Inês Boal-Carvalho, Luís Afonso, Paula Lopes, Roberto Roncon-Albuquerque, João-Bruno Soares, Elisabete Cardoso, Rui Henrique, Luís Moreira-Dias, Mário Dinis-Ribeiro, Adelino F Leite-Moreira.   

Abstract

BACKGROUND: Animal data suggest that Toll-like receptors (TLR) may play an important role in colon carcinogenesis. Studies in humans to support that hypothesis are scarce. AIM: To evaluate the expression of TLR2, TLR4 and TLR5, and the expression of several other related molecules, in different human colonic lesions.
METHODS: Colon biopsy samples from normal mucosa, normal mucosa adjacent to lesion, adenoma or sporadic carcinoma were obtained from 35 consecutive patients undergoing colonoscopy. Quantification of TLR2, TLR4, TLR5, Toll-interacting protein (TOLLIP), peroxisome proliferator-activated receptor γ (PPAR-γ), nuclear factor κB, tumour necrosis factor (TNF) α, cyclooxygenase (COX) 1 and 2 mRNA was performed by real-time reverse transcription PCR. TLR2, TLR4 and TLR5 protein expression was quantified by immunohistochemistry.
RESULTS: When compared with normal mucosa (1.0 arbitrary unit (AU)), adjacent normal mucosa presented higher expression of COX-2 (1.86±0.3 AU, p=0.01) and TNFα (1.44±0.18 AU, p=0.04) and lower TOLLIP expression (0.75±0.05 AU, p=0.004). Adenomas and carcinomas presented higher expression of COX-2 (1.63±0.27 and 1.38±0.14 AU, p=0.03 and p=0.05, respectively) and lower expression of TOLLIP (0.44±0.04 AU, p<0.001), with diffuse and higher TLR protein expression (p<0.001). Carcinomas also expressed higher TLR2 (2.31±0.32 AU, p=0.006) and lower PPAR-γ (0.56±0.12 AU, p=0.003). There was a trend towards decreased TOLLIP (p<0.001) and PPAR-γ (p=0.05) from normal mucosa to adenoma/carcinoma.
CONCLUSIONS: Persistently positive TLR expression and lower expression of TLR inhibitors was associated with higher TLR protein levels throughout the spectrum of lesions of colon carcinogenesis. Increasing activation of these receptors by bacteria may play a crucial role in colon carcinogenesis and tumour progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228906     DOI: 10.1136/jclinpath-2011-200567

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

Review 1.  The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors:  N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal:  Curr Gastroenterol Rep       Date:  2013-09

Review 2.  Epithelial Toll-like receptors and their role in gut homeostasis and disease.

Authors:  Juan F Burgueño; Maria T Abreu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-26       Impact factor: 46.802

3.  Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.

Authors:  Lauri Jouhi; Neeta Datta; Suvi Renkonen; Timo Atula; Antti Mäkitie; Caj Haglund; Abdirisak Ahmed; Stina Syrjänen; Reidar Grénman; Eeva Auvinen; Sanna Lehtonen; Jaana Hagström
Journal:  Tumour Biol       Date:  2015-05-05

4.  Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression.

Authors:  Romy E Verbeek; Peter D Siersema; Fiebo J Ten Kate; Kees Fluiter; Rhonda F Souza; Frank P Vleggaar; Pauline Bus; Jantine W P M van Baal
Journal:  J Gastroenterol       Date:  2013-08-17       Impact factor: 7.527

Review 5.  Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.

Authors:  Ting-Ting Li; Shuji Ogino; Zhi Rong Qian
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

6.  CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.

Authors:  Wei Zhang; Ting-Ting Xu; Zhen-Tao An; Lan-Fu Wei; Chao Gu; Hui Li; Yao-Zhou Tian
Journal:  J Gastrointest Oncol       Date:  2022-04

7.  Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis.

Authors:  Nian Wan; Xiaoxiong Liu; Xiao-Jing Zhang; Yichao Zhao; Gangying Hu; Fengwei Wan; Rui Zhang; Xueyong Zhu; Hao Xia; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

8.  Bioinformatic analyses revealed underlying biological functions correlated with oxaliplatin responsiveness.

Authors:  Sukhontip Klahan; Chi-Cheng Huang; Shu-Chen Chien; Mei-Shin Wu; Henry Sung-Ching Wong; Chien-Yu Huang; Wei-Chiao Chang; Po-Li Wei
Journal:  Tumour Biol       Date:  2015-08-02

Review 9.  Toll-interacting protein impacts on inflammation, autophagy, and vacuole trafficking in human disease.

Authors:  Xiaoyun Li; Gillian C Goobie; Yingze Zhang
Journal:  J Mol Med (Berl)       Date:  2020-10-31       Impact factor: 4.599

10.  Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein Arrays.

Authors:  María González-González; José María Sayagués; Luis Muñoz-Bellvís; Carlos Eduardo Pedreira; Marcello L R de Campos; Jacinto García; José Antonio Alcázar; Patrick F Braz; Breno L Galves; Luis Miguel González; Oscar Bengoechea; María Del Mar Abad; Juan Jesús Cruz; Lorena Bellido; Emilio Fonseca; Paula Díez; Pablo Juanes-Velasco; Alicia Landeira-Viñuela; Quentin Lecrevisse; Enrique Montalvillo; Rafael Góngora; Oscar Blanco; José Manuel Sánchez-Santos; Joshua LaBaer; Alberto Orfao; Manuel Fuentes
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.